Expert: Without J&J and AstraZeneca, we could be waiting until end of the year to fully vaccinate country

Results of US Drug Administration study of Johnson & Johnson vaccine will make or break our summer

The Johnson & Johnson (J&J) vaccine, the one-jab saviour, is disappearing quicker than Andre Agassi’s hair.

Yesterday its evaporation was rapid: first it was the US federal health and food authorities following reports it has caused blood clots among recipients, then the US government and the EU, and then the pharma company itself.

Like dominoes falling, heading towards the worst possible outcome: a continuation of restrictions, uncertainty and growing inequality between the ‘vaccinated’ and ‘have nots’.

Cruelly, the first consignment was due to arrive tomorrow.

8.2 million jabs down the toilet
Without the J&J and AstraZeneca jabs, experts warn that Denmark’s vaccination program might not be completed before the end of the year.

J&J accounted for 8.2 million of Denmark’s vaccinations. Even better, only one jab is necessary to vaccinate. On its own, it could have covered the whole country … and Latvia. Its withdrawal was unthinkable.

But its departure leaves Denmark with only Pfizer and Moderna in its arsenal.

“We can get to the finish line with Pfizer and Moderna,” Professor Jan Pravsgaard Christensen from the Department of Immunology and Microbiology at the University of Copenhagen told DR.

But then I think we will not be completely vaccinated until the end of 2021.”

Crucial assessment coming up
Six cases of blood clots have been recorded in the US among recipients of the J&J vaccine – all among women aged 18-48.

“We have reviewed the cases with the European health authorities, and we have chosen to postpone the rollout of the vaccine in Europe,” confirmed J&J yesterday.

The US Drug Administration will now conduct studies to assess whether it is still safe to use the vaccine. 

Forget the festivals!
“It makes sense for Johnson & Johnson to wait for it to be fully evaluated in the US before rolling it out in Europe,” continued Christensen, who believes the rest of the year could be bleak for most people in Denmark.

“You will still not be able to travel completely freely, go to festivals, go to the stadium and so on,” he predicted.

“However, we are well on our way to getting everyone over 50 vaccinated. Then we have the vulnerable out of the equation, so more reopening will still be possible.”





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.